Koers HansBiomed Corporation
Aandelen
A042520
KR7042520007
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13.180 KRW | -0,98% | -0,30% | -10,22% |
Omzet 2022 | 74,46 mld. 54,06 mln. 50,41 mln. | Omzet 2023 | 78,03 mld. 56,65 mln. 52,83 mln. | Marktkapitalisatie | 208 mld. 151 mln. 141 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 6,15 mld. 4,46 mln. 4,16 mln. | Nettowinst (verlies) 2023 | -23,04 mld. -16,73 mln. -15,6 mln. | EV/omzet 2022 | 1,82 x |
Nettoschuld 2022 | 42,36 mld. 30,75 mln. 28,68 mln. | Nettoschuld 2023 | 34,09 mld. 24,75 mln. 23,08 mln. | EV/omzet 2023 | 3,1 x |
K/w-verhouding 2022 |
53,3
x | K/w-verhouding 2023 |
-8,34
x | Werknemers | 254 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 60,39% |
1 dag | -0,98% | ||
1 week | -0,30% | ||
Lopende maand | -3,65% | ||
1 maand | -3,65% | ||
3 maanden | +15,11% | ||
6 maanden | -10,28% | ||
Lopend jaar | -10,22% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Geun-Young Kim
CEO | Chief Executive Officer | 60 | - |
Ho-Chan Hwang
BRD | Director/Board Member | 65 | - |
Chang-Hee Kim
AUD | Comptroller/Controller/Auditor | 58 | 06-12-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ho-Chan Hwang
BRD | Director/Board Member | 65 | - |
Geun-Young Kim
CEO | Chief Executive Officer | 60 | - |
Sang-Seok Oh
BRD | Director/Board Member | 54 | 26-12-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 13.180 | -0,98% | 29 320 |
29-04-24 | 13.310 | +3,26% | 39 793 |
26-04-24 | 12.890 | +0,62% | 22 355 |
25-04-24 | 12.810 | -3,17% | 44 632 |
24-04-24 | 13.230 | -.--% | 18 907 |
slotkoers Korea S.E., 30 april 2024
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,22% | 124 mln. | |
-9,45% | 10,69 mld. | |
+2,17% | 8,93 mld. | |
+19,94% | 7,32 mld. | |
+24,43% | 4,82 mld. | |
+7,46% | 3,4 mld. | |
-1,11% | 3,03 mld. | |
-5,07% | 2,23 mld. | |
-4,22% | 2,13 mld. | |
-20,87% | 1,84 mld. |